Official Information Act Request — Policy Contradictions in Drug Harm Statements and Regulatory Practice

 

Official Information Act Request — Policy Contradictions in Drug Harm Statements and Regulatory Practice

To: Office of the Minister for Mental Health
Cc: Ministry of Health / Medsafe
From: Nigel Gray NEW ZEALAND POLITICS (INCLUDES INTERNATIONAL)
Subject: Clarification of policy consistency regarding drug-harm statements, MDMA approval, and absence of safety monitoring systems

1. Ministerial Statement: “Drugs destroy lives.” (September 3rd 2026 facebook post)

Please provide any briefing papers, evidence summaries, or harm assessments that informed the Minister for Mental Health’s public statement:

“Drugs destroy lives.”

Specifically:

1.1. What definition of “drugs” was used for this statement?
1.2. Did this definition include MDMA in any form (illegal or therapeutic)?
1.3. If not, please provide the criteria used to exclude MDMA from the definition.

2. MDMA Approval — Comparison Between Medical and Illegal Use

(Directed to Medsafe / Ministry of Health)

Please provide:

2.1. Any comparative studies, evidence reviews, or internal analyses that outline the differences between:

• MDMA used in Medsafe‑approved therapeutic micro‑dosing, and
• MDMA used illegally in micro‑dosing or recreational contexts.

2.2. Any documents explaining why MDMA is considered safe enough for therapeutic approval, while illegal MDMA is considered harmful enough to fall under the Minister for Mental Health’s statement that “drugs destroy lives.”

2.3. Any internal discussion on how these distinctions are communicated to the public.

3. Absence of Suicide-Medication Tracking

(Directed to Ministry of Health / Health NZ)

Health NZ has previously confirmed that no system exists to record whether suicide cases involved prescribed psychiatric medication, despite these medications carrying suicide‑warning labels.

Please provide:

3.1. Any documents assessing whether the absence of suicide‑medication tracking is consistent with the Minister for Mental Health’s statement that “drugs destroy lives.”
3.2. Any internal discussion on whether the lack of tracking creates preventable blind spots in harm detection.
3.3. Any analysis on whether medication‑related suicidality can be identified without such a tracking system.

4. Absence of Nutritional Monitoring for Medicated Patients

(Directed to Ministry of Health / Health NZ)

Psychiatric medications are known to alter appetite, metabolism, and micronutrient levels, yet Health NZ has no mandatory nutritional monitoring requirements.

Please provide:

4.1. Any policies, guidelines, or evidence reviews relating to nutritional monitoring for patients prescribed psychiatric medication.
4.2. Any documents assessing whether the absence of nutritional monitoring is consistent with the Minister for Mental Health’s statement that “drugs destroy lives.”
4.3. Any internal discussion on whether nutritional deterioration contributes to medication‑related harm, and whether any safeguards exist to prevent this.

5. Consistency of Public Messaging and Regulatory Practice

(Directed jointly to the Minister for Mental Health, Ministry of Health, and Medsafe)

Please provide any documents assessing whether the following positions are internally consistent:

• The Minister for Mental Health’s statement that “drugs destroy lives.”
• Medsafe’s approval of MDMA-assisted therapy trials.
• The absence of suicide‑medication tracking systems.
• The absence of nutritional monitoring systems for medicated patients.

Closing

This request seeks clarification on how public drug-harm messaging aligns with regulatory decisions and the absence of basic safety monitoring systems.